Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2645306rdf:typepubmed:Citationlld:pubmed
pubmed-article:2645306lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2645306lifeskim:mentionsumls-concept:C0010481lld:lifeskim
pubmed-article:2645306lifeskim:mentionsumls-concept:C0020459lld:lifeskim
pubmed-article:2645306lifeskim:mentionsumls-concept:C0023401lld:lifeskim
pubmed-article:2645306lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2645306lifeskim:mentionsumls-concept:C0022702lld:lifeskim
pubmed-article:2645306pubmed:issue2lld:pubmed
pubmed-article:2645306pubmed:dateCreated1989-3-27lld:pubmed
pubmed-article:2645306pubmed:abstractTextAs muscle wasting and resistance to insulin-mediated glucose utilization are features of Cushing's syndrome (CS), we examined glucose and amino acid metabolism in six patients with CS and six normal subjects before and during euglycemic hyperinsulinemic clamp studies (plasma insulin concentrations, approximately 0.36, approximately 0.65, and approximately 10.05 mmol/L). The two groups had similar body mass index values. In the postabsorptive state, leucine and alpha-ketoisocaproate (KIC) rates of appearance (Ra), KIC oxidation, and nonoxidized leucine-carbon flux, an index of leucine entering protein (Leu----P), were comparable in CS patients [2.38 +/- 0.14 (+/- SE), 0.22 +/- 0.04, and 2.16 +/- 0.12 mumol/kg.min) and in normal subjects (2.73 +/- 0.25, 0.17 +/- 0.02, and 2.59 +/- 0.22 mumol/kg.min). During the euglycemic clamp studies the leucine and KIC Ra values, KIC oxidation, and Leu----P decreased to a similar extent in both groups. In contrast, insulin-mediated glucose utilization was impaired in the CS patients at each clamp step (P less than 0.05). In summary, postabsorptive whole body leucine metabolism is normal in patients with CS and is normally suppressed by hyperinsulinemia, indicating a dissociation in insulin sensitivity with respect to glucose and amino acid metabolism.lld:pubmed
pubmed-article:2645306pubmed:languageenglld:pubmed
pubmed-article:2645306pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2645306pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2645306pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2645306pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2645306pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2645306pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2645306pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2645306pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2645306pubmed:statusMEDLINElld:pubmed
pubmed-article:2645306pubmed:monthFeblld:pubmed
pubmed-article:2645306pubmed:issn0021-972Xlld:pubmed
pubmed-article:2645306pubmed:authorpubmed-author:TiengoAAlld:pubmed
pubmed-article:2645306pubmed:authorpubmed-author:ManteroFFlld:pubmed
pubmed-article:2645306pubmed:authorpubmed-author:TessariPPlld:pubmed
pubmed-article:2645306pubmed:authorpubmed-author:FantinGGlld:pubmed
pubmed-article:2645306pubmed:authorpubmed-author:MerolaGGlld:pubmed
pubmed-article:2645306pubmed:authorpubmed-author:InchiostroSSlld:pubmed
pubmed-article:2645306pubmed:authorpubmed-author:BioloGGlld:pubmed
pubmed-article:2645306pubmed:authorpubmed-author:MarescottiM...lld:pubmed
pubmed-article:2645306pubmed:authorpubmed-author:BoscaratoM...lld:pubmed
pubmed-article:2645306pubmed:issnTypePrintlld:pubmed
pubmed-article:2645306pubmed:volume68lld:pubmed
pubmed-article:2645306pubmed:ownerNLMlld:pubmed
pubmed-article:2645306pubmed:authorsCompleteYlld:pubmed
pubmed-article:2645306pubmed:pagination256-62lld:pubmed
pubmed-article:2645306pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:2645306pubmed:meshHeadingpubmed-meshheading:2645306-...lld:pubmed
pubmed-article:2645306pubmed:meshHeadingpubmed-meshheading:2645306-...lld:pubmed
pubmed-article:2645306pubmed:meshHeadingpubmed-meshheading:2645306-...lld:pubmed
pubmed-article:2645306pubmed:meshHeadingpubmed-meshheading:2645306-...lld:pubmed
pubmed-article:2645306pubmed:meshHeadingpubmed-meshheading:2645306-...lld:pubmed
pubmed-article:2645306pubmed:meshHeadingpubmed-meshheading:2645306-...lld:pubmed
pubmed-article:2645306pubmed:meshHeadingpubmed-meshheading:2645306-...lld:pubmed
pubmed-article:2645306pubmed:meshHeadingpubmed-meshheading:2645306-...lld:pubmed
pubmed-article:2645306pubmed:meshHeadingpubmed-meshheading:2645306-...lld:pubmed
pubmed-article:2645306pubmed:meshHeadingpubmed-meshheading:2645306-...lld:pubmed
pubmed-article:2645306pubmed:meshHeadingpubmed-meshheading:2645306-...lld:pubmed
pubmed-article:2645306pubmed:meshHeadingpubmed-meshheading:2645306-...lld:pubmed
pubmed-article:2645306pubmed:meshHeadingpubmed-meshheading:2645306-...lld:pubmed
pubmed-article:2645306pubmed:meshHeadingpubmed-meshheading:2645306-...lld:pubmed
pubmed-article:2645306pubmed:year1989lld:pubmed
pubmed-article:2645306pubmed:articleTitleLeucine kinetics and the effects of hyperinsulinemia in patients with Cushing's syndrome.lld:pubmed
pubmed-article:2645306pubmed:affiliationCattedra di Malattie del Ricambio, University of Padova, Italy.lld:pubmed
pubmed-article:2645306pubmed:publicationTypeJournal Articlelld:pubmed